| Targeting HIF-1 for cancer therapy | Nature Reviews Cancer | 2003 | 5.3K |
| Photodynamic therapy for cancer | Nature Reviews Cancer | 2003 | 4.6K |
| The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Nature Reviews Cancer | 2003 | 3.4K |
| Identification of a cancer stem cell in human brain tumors | Cancer Research | 2003 | 3.4K |
| 5-fluorouracil: mechanisms of action and clinical strategies | Nature Reviews Cancer | 2003 | 3.2K |
| Cancer statistics, 2003 | Ca-A Cancer Journal for Clinicians | 2003 | 2.8K |
| Tumorigenesis and the angiogenic switch | Nature Reviews Cancer | 2003 | 2.7K |
| Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected] | Journal of Clinical Oncology | 2003 | 2.5K |
| Cisplatin: mode of cytotoxic action and molecular basis of resistance | Oncogene | 2003 | 2.4K |
| Targeting RAS signalling pathways in cancer therapy | Nature Reviews Cancer | 2003 | 2.4K |
| Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 | Leukemia | 2003 | 2.4K |
| Tumour-cell invasion and migration: diversity and escape mechanisms | Nature Reviews Cancer | 2003 | 2.4K |
| Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Journal of Clinical Oncology | 2003 | 2.3K |
| Cancer chemoprevention with dietary phytochemicals | Nature Reviews Cancer | 2003 | 2.2K |
| Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia | Journal of Clinical Oncology | 2003 | 2.1K |
| ATM and related protein kinases: safeguarding genome integrity | Nature Reviews Cancer | 2003 | 2.1K |
| A 5-decade analysis of 13,715 carcinoid tumors | Cancer | 2003 | 2.1K |
| A multigenic program mediating breast cancer metastasis to bone | Cancer Cell | 2003 | 2.1K |
| CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment | Seminars in Radiation Oncology | 2003 | 2K |
| Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor | Journal of Clinical Oncology | 2003 | 1.9K |
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Cancer Cell | 2003 | 1.8K |
| MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer | Oncogene | 2003 | 1.7K |
| Neuroblastoma: biological insights into a clinical enigma | Nature Reviews Cancer | 2003 | 1.6K |
| Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study | Journal of Clinical Oncology | 2003 | 1.6K |
| Anticancer potential of curcumin: preclinical and clinical studies | Anticancer Research | 2003 | 1.6K |
